Progyny (NASDAQ:PGNY) Insider Geoffrey Clapp Sells 1,530 Shares of Stock

Progyny, Inc. (NASDAQ:PGNY) insider Geoffrey Clapp sold 1,530 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $25.58, for a total transaction of $39,137.40. Following the sale, the insider owned 59,117 shares of the company’s stock, valued at $1,512,212.86. The trade was a 2.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Progyny Stock Performance

Shares of Progyny stock opened at $24.99 on Thursday. The firm has a fifty day moving average of $20.27 and a two-hundred day moving average of $22.26. The stock has a market capitalization of $1.96 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 1.34 and a beta of 1.03. Progyny, Inc. has a 52 week low of $16.10 and a 52 week high of $28.75.

Progyny (NASDAQ:PGNY) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.24. The business had revenue of $328.50 million during the quarter, compared to the consensus estimate of $326.47 million. Progyny had a return on equity of 13.34% and a net margin of 5.23%.The firm’s revenue was down 26.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.17 earnings per share. Progyny has set its FY 2026 guidance at 1.980-2.09 EPS and its Q2 2026 guidance at 0.500-0.53 EPS. As a group, research analysts forecast that Progyny, Inc. will post 1.12 EPS for the current fiscal year.

Progyny announced that its board has approved a share repurchase plan on Tuesday, May 26th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to buy up to 10.3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its stock is undervalued.

Analysts Set New Price Targets

PGNY has been the subject of a number of recent analyst reports. Citigroup reiterated an “outperform” rating on shares of Progyny in a report on Monday, May 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Progyny in a report on Friday, March 27th. Bank of America upped their price objective on Progyny from $29.00 to $31.00 and gave the company a “buy” rating in a report on Tuesday. Zacks Research upgraded Progyny from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Finally, Canaccord Genuity Group raised Progyny from a “hold” rating to a “buy” rating and boosted their target price for the company from $19.00 to $30.00 in a research note on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Progyny presently has an average rating of “Moderate Buy” and a consensus target price of $29.67.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Segall Bryant & Hamill LLC grew its stake in Progyny by 68.4% in the first quarter. Segall Bryant & Hamill LLC now owns 82,198 shares of the company’s stock valued at $1,396,000 after acquiring an additional 33,380 shares during the period. Bank of America Corp DE grew its stake in Progyny by 75.3% in the first quarter. Bank of America Corp DE now owns 1,190,996 shares of the company’s stock valued at $20,223,000 after acquiring an additional 511,609 shares during the period. South Dakota Investment Council grew its stake in Progyny by 20.0% in the first quarter. South Dakota Investment Council now owns 137,524 shares of the company’s stock valued at $2,335,000 after acquiring an additional 22,900 shares during the period. Amundi bought a new position in Progyny during the 1st quarter worth about $180,000. Finally, California State Teachers Retirement System increased its holdings in Progyny by 30.4% during the 1st quarter. California State Teachers Retirement System now owns 99,753 shares of the company’s stock worth $1,694,000 after purchasing an additional 23,273 shares in the last quarter. 94.93% of the stock is owned by institutional investors and hedge funds.

Progyny Company Profile

Progyny, Inc is a New York-based fertility benefits management company that partners with employers and health plans to design and administer comprehensive family-building programs. The company’s digital health platform integrates clinical expertise, patient support tools and data analytics to help members navigate fertility treatments, from in vitro fertilization (IVF) and egg freezing to surrogacy and adoption. By focusing on outcomes-based care, Progyny aims to improve success rates while controlling costs for its clients.

The core of Progyny’s offering is its proprietary Smart Cycle® benefit, which bundles clinical, emotional and logistical support into a single package.